샘플 요청 목록

 카트 문의
시장보고서
상품코드
1625446

동물용 항생제 시장 점유율, 규모, 동향, 산업 분석 보고서 : 동물 유형별, 약제 클래스별, 제형별, 지역별 - 시장 예측(2025-2034년)

Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type, Drug Class, Dosage Form, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 122 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 동물용 항생제 시장 규모는 2034년까지 64억 3,000만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

동물용 항생제는 동물의 박테리아 감염을 치료하기 위해 특별히 고안된 약물입니다. 항생제는 해로운 박테리아를 제거하거나 그 성장을 억제하여 동물의 회복을 돕습니다.

주요 기업의 이니셔티브와 신제품 출시로 인해 동물 전용 항생제와 이오노포어에 대한 중요성이 점점 더 강조되고 있습니다. 가축의 질병은 증가하는 경향이 있으며, 주요 기업들은 수요에 부응하기 위해 새로운 항생제를 적극적으로 출시하고 있습니다.

동물용 항생제 시장은 인류 공통 감염에 대한 의식 증가, 동물 질병 발생 증가, 동물 유래 식품 수요 증가로 예측 기간 동안 성장할 것으로 예상됩니다. 또한 엄격한 질병 예방 규제, 동물 인구 증가, 반려동물 사육 증가, 반려동물 건강 보험 시장의 확대가 시장 성장을 가속하고 있습니다.

동물의 사육이 증가함에 따라 항생제를 포함한 수의학 서비스 및 제품에 대한 수요가 촉진됩니다. 반려동물을 집으로 데려오는 사람들이 늘어남에 따라 동물의 건강 관리, 예방 조치 및 치료의 필요성은 세계적으로 계속 증가하고 있습니다.

2024년 7월 중앙 질병 관리 보고서에 따르면 동물과 인간 사이에 감염되는 인수 공통 감염병의 예방에는 효과적인 관리를 위한 원헬스 접근이 필요합니다. 주목할만한 것은 HIV와 광견병과 같은 병원체를 포함한 인간 감염병의 60%가 동물에서 유래한다는 것입니다. 게다가 신흥 감염병의 대부분과 탄저병과 같은 바이오테러 관련 질환의 80%는 인수 공통 감염병입니다. 동물들 사이에서 이러한 질병의 발생이 증가하고 있다는 것은 동물용 항생제 시장의 확대를 뒷받침하고 있습니다.

동물용 항생제 보고서 하이라이트

동물 유형별로, 강화된 동물의 건강 관리를 필요로 하는 쇠고기 및 유제품 소비량이 증가함에 따라 2024년에는 암소 부문이 동물용 항생제 시장을 독점했습니다.

약물 등급별로, 2024년에는 테트라사이클린 시스템이 치료 용도에서 시장을 독점했습니다. 이 항생제는 식용 동물의 첫 번째 선택 치료제로 널리 사용되며 개, 고양이, 말과 같은 반려 동물에게도 자주 투여됩니다. 아크로마이신, 수마이신, 메디사이클린, 테트라신과 같은 테트라사이클린계 약물은 특히 동물의 박테리아 감염과 염증성 피부 질환에 대처하기 위해 수의학에서 사용됩니다.

유럽의 수의사 시장은 사료, 건강 관리, 그루밍 등 반려동물 케어에 대한 지출이 많기 때문에 향후 수년간 성장할 것으로 예상됩니다. 또한 스마트 반려동물 장치와 같은 기술 발전도 시장 성장에 기여하고 있습니다. 소비자의 취향 변화, 특히 다이어트와 채식주의 반려동물 먹이에 대한 수요 증가도 시장 성장을 지원합니다.

세계 주요 시장 기업의 예로는 Merck &Co., Inc., Ceva Sante Animale, Vetoquinol, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Virbac SA, Calier, Bimeda ., Prodivet Pharmaceuticals SA/NV, Norbrook Laboratories 등을 들 수 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계 동물용 항생제 시장 인사이트

  • 시장 현황
  • 동물용 항생제 시장 역학
    • 성장 촉진요인과 기회
      • 동물 유래 식품 수요 증가
      • 가축질병의 발생 증가
    • 성장 억제요인과 과제
      • 엄격한 규제
  • PESTEL 분석
  • 동물용 항생제 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 동물용 항생물질 시장 : 동물 유형별

  • 주요 조사 결과
  • 소개
  • 돼지
  • 소
  • 양 및 염소
  • 가금류
  • 기타

제6장 세계의 동물용 항생물질 시장 : 약제 클래스별

  • 주요 조사 결과
  • 소개
  • 테트라사이클린
  • 페니실린
  • 술폰아미드
  • 마크로라이드
  • 트리메트프림
  • 린코사미드
  • 폴리믹신
  • 아미노글리코시드
  • 플루오로퀴놀론
  • 프리우롬칠린
  • 기타

제7장 세계의 동물용 항생물질 시장 : 제형별

  • 주요 조사 결과
  • 소개
  • 경구용 분말
  • 경구용액
  • 주사
  • 기타

제8장 세계의 동물용 항생물질 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 동물용 항생제 시장 평가 : 지역(2020-2034년)
  • 북미
    • 북미 : 동물 유형별(2020-2034년)
    • 북미 : 약제 클래스별(2020-2034년)
    • 북미 : 제형별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 동물 유형별(2020-2034년)
    • 유럽 : 약제 클래스별(2020-2034년)
    • 유럽 : 제형별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 동물 유형별(2020-2034년)
    • 아시아태평양 : 약제 클래스별(2020-2034년)
    • 아시아태평양 : 제형별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 동물 유형별(2020-2034년)
    • 중동 및 아프리카 : 약제 클래스별(2020-2034년)
    • 중동 및 아프리카 : 제형별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 동물 유형별(2020-2034년)
    • 라틴아메리카 : 약제 클래스별(2020-2034년)
    • 라틴아메리카 : 제형별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 파트너십/협업/계약/공개

제10장 기업 프로파일

  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Calier
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Norbrook Laboratories
  • Prodivet Pharmaceuticals SA/NV
  • Vetoquinol
  • Virbac SA
  • Zoetis Services LLC
KTH 25.02.03

The global veterinary antibiotics market size is expected to reach USD 6.43 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, and Others), Drug Class, Dosage Form, and Region (North America, Europe, Asia Pacific, and Rest of World) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary antibiotics are medications specifically designed for treating bacterial infections in animals. The antibiotics eliminate harmful bacteria or inhibit their growth, thus assisting in the animal's recovery.

There is a growing emphasis on animal-specific antibiotics and ionophores, driven by initiatives from major companies and the introduction of new products. The incidence of livestock diseases is on the rise, leading key players to actively release new antibiotics to meet demand, especially as older antibiotics have been linked to resistance.

The veterinary antibiotics market is expected to grow during the forecast period due to increased awareness of zoonotic diseases, rising animal disease outbreaks, and higher demand for animal-derived food products. Additionally, stringent disease prevention regulations, a growing animal population, increased pet adoption, and the expanding pet health insurance market are driving the market growth.

The increasing adoption of companion animals is propelling the demand for veterinary services and products, including antibiotics. As more people bring pets into their homes, the need for healthcare, preventive measures, and treatments for these animals continues to increase globally.

According to the central disease control report in July 2024, prevention of Zoonotic diseases, which are transmissible between animals and humans, requires a One Health approach for effective management. Notably, 60% of human infectious diseases originate from animals, including pathogens such as HIV and rabies. Additionally, most emerging infectious diseases and 80% of bioterrorism-related diseases, such as anthrax, are zoonotic. The increasing incidence of such diseases among animals boosts the veterinary antibiotics market expansion.

Veterinary Antibiotics Report Highlights

By animal type, the cattle segment dominated the veterinary antibiotics market in 2024 due to the rising consumption of beef and dairy products that necessitate enhanced animal health management.

Based on drug class, in 2024, the tetracyclines segment dominated the market due to their therapeutic applications. These antibiotics are widely used as first-line treatments for food-producing animals and are also frequently administered to companion animals, including dogs, cats, and horses. Tetracycline-based medications such as Achromycin, Sumycin, Medicycline, and Tetracyn are specifically used in veterinary medicine to address bacterial infections and inflammatory skin conditions in animals.

The European veterinary market is expected to grow in the coming years due to the high expenditure on pet care, encompassing food, healthcare, and grooming. Furthermore, technological advancements such as smart pet devices are contributing to the market growth. Shifting consumer preferences, particularly the increasing demand for dietary and vegan pet food, also support the market growth.

A few global key market players are Merck & Co., Inc.; Ceva Sante Animale; Vetoquinol; Zoetis Services LLC; Boehringer Ingelheim International GmbH; Dechra Pharmaceuticals PLC; Elanco Animal Health Incorporated; Virbac S.A.; Calier, Bimeda, Inc.; Prodivet Pharmaceuticals SA/NV; and Norbrook Laboratories.

Polaris Market Research has segmented the veterinary antibiotics market report on the basis of animal type, drug class, dosage form, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

  • Pigs
  • Cattle
  • Sheep & Goats
  • Poultry
  • Others

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Trimethoprim
  • Lincosamides
  • Polymyxins
  • Aminoglycosides
  • Fluoroquinolones
  • Pleuromutilins
  • Other

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

  • Oral Powders
  • Oral Solutions
  • Injections
  • Other

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Antibiotics Market Insights

  • 4.1. Veterinary Antibiotics Market - Market Snapshot
  • 4.2. Veterinary Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Animal-Derived Food Products
      • 4.2.1.2. Increasing Incidence of Livestock Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Antibiotics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Antibiotics Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
  • 5.3. Pigs
    • 5.3.1. Global Veterinary Antibiotics Market, by Pigs, by Region, 2020-2034 (USD Billion)
  • 5.4. Cattle
    • 5.4.1. Global Veterinary Antibiotics Market, by Cattle, by Region, 2020-2034 (USD Billion)
  • 5.5. Sheep & Goats
    • 5.5.1. Global Veterinary Antibiotics Market, by Sheep & Goats, by Region, 2020-2034 (USD Billion)
  • 5.6. Poultry
    • 5.6.1. Global Veterinary Antibiotics Market, by Poultry, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Antibiotics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
  • 6.3. Tetracyclines
    • 6.3.1. Global Veterinary Antibiotics Market, by Tetracyclines, by Region, 2020-2034 (USD Billion)
  • 6.4. Penicillins
    • 6.4.1. Global Veterinary Antibiotics Market, by Penicillins, by Region, 2020-2034 (USD Billion)
  • 6.5. Sulfonamides
    • 6.5.1. Global Veterinary Antibiotics Market, by Sulfonamides, by Region, 2020-2034 (USD Billion)
  • 6.6. Macrolides
    • 6.6.1. Global Veterinary Antibiotics Market, by Macrolides, by Region, 2020-2034 (USD Billion)
  • 6.7. Trimethoprim
    • 6.7.1. Global Veterinary Antibiotics Market, by Trimethoprim, by Region, 2020-2034 (USD Billion)
  • 6.8. Lincosamides
    • 6.8.1. Global Veterinary Antibiotics Market, by Lincosamides, by Region, 2020-2034 (USD Billion)
  • 6.9. Polymyxins
    • 6.9.1. Global Veterinary Antibiotics Market, by Polymyxins, by Region, 2020-2034 (USD Billion)
  • 6.10. Aminoglycosides
    • 6.10.1. Global Veterinary Antibiotics Market, by Aminoglycosides, by Region, 2020-2034 (USD Billion)
  • 6.11. Fluoroquinolones
    • 6.11.1. Global Veterinary Antibiotics Market, by Fluoroquinolones, by Region, 2020-2034 (USD Billion)
  • 6.12. Pleuromutilins
    • 6.12.1. Global Veterinary Antibiotics Market, by Pleuromutilins, by Region, 2020-2034 (USD Billion)
  • 6.13. Others
    • 6.13.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Antibiotics Market, by Dosage Form

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 7.3. Oral Powders
    • 7.3.1. Global Veterinary Antibiotics Market, by Oral Powders, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Solutions
    • 7.4.1. Global Veterinary Antibiotics Market, by Oral Solutions, by Region, 2020-2034 (USD Billion)
  • 7.5. Injections
    • 7.5.1. Global Veterinary Antibiotics Market, by Injections, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Veterinary Antibiotics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Veterinary Antibiotics Market - North America
    • 8.3.1. North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.3.3. North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.4. Veterinary Antibiotics Market - U.S.
      • 8.3.4.1. U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.5. Veterinary Antibiotics Market - Canada
      • 8.3.5.1. Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.4. Veterinary Antibiotics Market - Europe
    • 8.4.1. Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.4. Veterinary Antibiotics Market - UK
      • 8.4.4.1. UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.5. Veterinary Antibiotics Market - France
      • 8.4.5.1. France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.6. Veterinary Antibiotics Market - Germany
      • 8.4.6.1. Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.7. Veterinary Antibiotics Market - Italy
      • 8.4.7.1. Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.8. Veterinary Antibiotics Market - Spain
      • 8.4.8.1. Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.9. Veterinary Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.10. Veterinary Antibiotics Market - Russia
      • 8.4.10.1. Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.11. Veterinary Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.5. Veterinary Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.4. Veterinary Antibiotics Market - China
      • 8.5.4.1. China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.5. Veterinary Antibiotics Market - India
      • 8.5.5.1. India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.6. Veterinary Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.7. Veterinary Antibiotics Market - Japan
      • 8.5.7.1. Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.8. Veterinary Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.9. Veterinary Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.10. Veterinary Antibiotics Market - Australia
      • 8.5.10.1. Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.11. Veterinary Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.6. Veterinary Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.4. Veterinary Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.5. Veterinary Antibiotics Market - UAE
      • 8.6.5.1. UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.6. Veterinary Antibiotics Market - Israel
      • 8.6.6.1. Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.7. Veterinary Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.8. Veterinary Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.7. Veterinary Antibiotics Market - Latin America
    • 8.7.1. Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.4. Veterinary Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.5. Veterinary Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.6. Veterinary Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.7. Veterinary Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bimeda, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Boehringer Ingelheim International GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Calier
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ceva Sante Animale
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dechra Pharmaceuticals PLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Elanco Animal Health Incorporated
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck & Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Norbrook Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Prodivet Pharmaceuticals SA/NV
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Vetoquinol
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Virbac S.A.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Zoetis Services LLC
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제